Sign in Subscribe

diabetes

diabetes

Fueled by $13.5 Million Investment, An Atlanta Pro Cyclist Is Rethinking Glucose Monitoring For Athletes

Fueled by $13.5 Million Investment, An Atlanta Pro Cyclist Is Rethinking Glucose Monitoring For Athletes

Endurance athletes measure everything. From sleep to heart rate to food intake, logging key insights can help the pros reach peak performance. But Atlanta-based Phil Southerland knew that such tracking had its limits. As a professional cyclist and co-founder of Team Novo Nordisk, Southerland recognized there was no

Physician-Founded Telmedix Puts Specialty Medical Consults Right In the Primary Care Clinic

Physician-Founded Telmedix Puts Specialty Medical Consults Right In the Primary Care Clinic

A patient with chronic ailments generally sees several specialty physicians, whom often operate in silos. These individuals deal with scheduling different offices, finding reliable transportation, and the challenge of taking days off of work. This general lack of convenience may deter the same patient from pursuing referral appointments following up

Inspired by Diabetes Alert Dogs, AerBetic Sniffs Out Low Blood Sugar With A Wearable

Inspired by Diabetes Alert Dogs, AerBetic Sniffs Out Low Blood Sugar With A Wearable

More than 30 million Americans have diabetes, with 1.5 million new cases diagnosed every year. To monitor fluctuating blood glucose levels, Type 1 diabetics have to prick their finger daily. Current solutions remain invasive, painful, and a nuisance. Arnar Thors learned about diabetes service dogs when he came across

Digital Health Startup Rimidi Is Getting to the Heart of the Chronic Disease Epidemic: Underserved Neighborhoods

Digital Health Startup Rimidi Is Getting to the Heart of the Chronic Disease Epidemic: Underserved Neighborhoods

Rimidi, an Atlanta-based digital health startup addressing chronic conditions, has partnered with CVS on a pilot to try to reduce diabetes in underserved neighborhoods in Atlanta. The pilot will work by engaging diabetes patients or those at a high risk for the disease both digitally and in-person. The